Workflow
Dyadic(DYAI) - 2024 Q3 - Quarterly Results
DYAIDyadic(DYAI)2024-11-12 21:11

Exhibit 99.1 Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins ● Demonstrated substantial revenue increase for Q3 2024, driven primarily by Dapibus™ license fees and milestone payments. ● Received 1millionmilestonepaymentforanimal−freerecombinantalbuminproducts.●Received1 million milestone payment for animal-free recombinant albumin products. ● Received 425,000 success fees for achi ...